AXIM Biotech Advisory Board Member Presented at CannMed 2017 Personalized Cannabinoid Medicine Conference at Harvard
13 avr. 2017 09h00 HE
|
AXIM Biotechnologies, Inc
NEW YORK, April 13, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that Dr. Ilya Reznik, a...
AXIM® Biotech Expands Advisory Board With Psychiatry Specialist – Dr. Ilya Reznik
13 déc. 2016 09h00 HE
|
AXIM Biotechnologies, Inc
NEW YORK, Dec. 13, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, announces the addition to its advisory...